EC Plans New Structures For Manufacturers Of High-Risk IVDs Soon
Among the missing elements of the EU IVD Regulation are designated reference laboratories, which are to play a key role in assessing class D IVDs. That should change by around early 2024.
You may also be interested in...
Work related to the European Commission’s promise to assess the impact of the Medical Device Regulation, including its impact on innovation, is starting to take shape.
Medtech developers have just over a month to apply for the pilot phase of a program offering regulatory and practical support to accelerate innovative product access to the UK NHS.
The European Commission has conceded to the medtech industry’s calls to delay and modify the new EU regulatory requirements multiple times over the last few years. But will it yield to fresh calls for radical changes being sought by the most powerful lobby yet?